Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Conley

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Clinical Neuropharmacology|November 4, 2008
The effects of galantamine on psychopathology in chronic stable schizophreniaRobert R Conley, Douglas L Boggs, Deanna L Kelly, et al.
The Journal of Clinical Psychiatry|October 5, 2006
Clozapine utilization and outcomes by race in a public mental health system: 1994-2000Deanna L Kelly, Lisa B Dixon, Julie A Kreyenbuhl, et al.
The Journal of Clinical Psychiatry|August 5, 2011
Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidoneBonnie A Fijal, Virginia L Stauffer, Bruce J Kinon, et al.
The Journal of Clinical Psychiatry|January 19, 2010
Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort studyDeanna L Kelly, Robert P McMahon, Fang Liu, et al.
The Journal of Clinical Psychiatry|October 5, 2006
Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional studyDo-Un Jung, Robert R Conley, Deanna L Kelly, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 29, 2010
Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapineElaine Weiner, Robert R Conley, M Patricia Ball, et al.
The American Journal of Psychiatry|March 1, 2002
Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victimsGhanshyam N Pandey, Yogesh Dwivedi, Hooriyah S Rizavi, et al.
The American Journal of Psychiatry|August 31, 2007
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trialJoo-Cheol Shim, Jae-Goo K Shin, Deanna L Kelly, et al.
The Journal of Clinical Psychiatry|September 13, 2012
Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophreniaJohn P Houston, Jared Kohler, Jeffrey R Bishop, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 17, 2008
Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophreniaIkwunga Wonodi, L Elliot Hong, O Colin Stine, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Clinical Neuropharmacology|November 4, 2008
The effects of galantamine on psychopathology in chronic stable schizophreniaRobert R Conley, Douglas L Boggs, Deanna L Kelly, et al.
The Journal of Clinical Psychiatry|October 5, 2006
Clozapine utilization and outcomes by race in a public mental health system: 1994-2000Deanna L Kelly, Lisa B Dixon, Julie A Kreyenbuhl, et al.
The Journal of Clinical Psychiatry|August 5, 2011
Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidoneBonnie A Fijal, Virginia L Stauffer, Bruce J Kinon, et al.
The Journal of Clinical Psychiatry|January 19, 2010
Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort studyDeanna L Kelly, Robert P McMahon, Fang Liu, et al.
The Journal of Clinical Psychiatry|October 5, 2006
Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional studyDo-Un Jung, Robert R Conley, Deanna L Kelly, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 29, 2010
Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapineElaine Weiner, Robert R Conley, M Patricia Ball, et al.
The American Journal of Psychiatry|March 1, 2002
Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victimsGhanshyam N Pandey, Yogesh Dwivedi, Hooriyah S Rizavi, et al.
The American Journal of Psychiatry|August 31, 2007
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trialJoo-Cheol Shim, Jae-Goo K Shin, Deanna L Kelly, et al.
The Journal of Clinical Psychiatry|September 13, 2012
Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophreniaJohn P Houston, Jared Kohler, Jeffrey R Bishop, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 17, 2008
Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophreniaIkwunga Wonodi, L Elliot Hong, O Colin Stine, et al.
Pageof 12